!function(s,a,e,v,n,t,z){if(s.saq)return;n=s.saq=function(){n.callMethod?n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!s._saq)s._saq=n;n.push=n;n.loaded=!0;n.version='1.0';n.queue=[];t=a.createElement(e);t.async=!0;t.data-privacy-src=v;z=a.getElementsByTagName(e)[0];z.parentNode.insertBefore(t,z)}(window,document,'script','https://tags.srv.stackadapt.com/events.js');saq('ts', 'hqvUkGggBAQuL-fcnFloOA'); Skip to content
Alzheon | Preserving Future Memories LogoAlzheon | Preserving Future Memories Logo
  • Home
  • People
    • About Us
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact
  • Patients
    • Our Vision
    • Expanded Access Policy
  • Science
    • Pipeline
    • Mechanism of Action
    • Publications
    • Posters
    • AAIC 2025 Symposium Presentation
    • AD/PD 2025 Symposium Presentation
  • Careers
  • Media
    • Press Releases
    • In The News
  • Home
  • People
    • About Us
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact
  • Patients
    • Our Vision
    • Expanded Access Policy
  • Science
    • Pipeline
    • Mechanism of Action
    • Publications
    • Posters
    • AAIC 2025 Symposium Presentation
    • AD/PD 2025 Symposium Presentation
  • Careers
  • Media
    • Press Releases
    • In The News

Advances in AD Treatments

The Science Behind the Drug That May Stop Alzheimer’s Disease in Its Tracks

3 min video | 1 min read

A First of Its Kind, ALZ-801 Aims To Preserve Memories, Save Lives: An Exclusive Interview with Dr. Martin Tolar

8 min video | 1 min read

Unprecedented Reduction in Key Alzheimer’s Biomarker for Patients Treated With ALZ-801

6 min video | 1 min read

Part 1: The Role of APOE Genotyping in Alzheimer’s Disease Risk Stratification

8 min video

Part 2: APOE Genotyping in Clinical Practice: Pros and Cons

8 min video

Learn More About Advances in AD Treatments

3 min read

Learn More About Advances in AD Treatments

For more information, review the following articles that offer further insight into the latest progress in Alzheimer’s care.

New content added!

Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach

Emerging Alzheimer’s disease therapies target amyloid protein

The latest advances in Alzheimer’s research

Precision treatment for Alzheimer’s disease reduces phosphorylated tau

ALZ-801 trial results announced: A breakthrough in Alzheimer’s treatment?

Previous Article
Next Article
alzheon2023-07-20T10:28:14-04:00

Newsletter

Sign up for updates

Get the latest Alzheon news in your inbox.

Not seeing the signup form? An ad or privacy blocker may be hiding it – email info@alzheon.com and we’ll add you to the list.

Alzheon – Preserving future memories

Alzheon, Inc.
111 Speen Street, Suite 306
Framingham, MA 01701, USA
508-861-7709

Company

  • About Us
  • Management Team
  • Board of Directors
  • Scientific Advisory Board
  • Careers

Science

  • Our Pipeline
  • Mechanism of Action
  • Scientific Publications
  • Scientific Posters
  • Key Publications (PDF)

Patients & Media

  • Our Vision
  • Expanded Access Policy
  • In The News
  • Press Releases
  • Contact

© 2026 Alzheon, Inc. All rights reserved.

Privacy PolicyContact
Page load link
This website uses cookies and third-party services. By clicking "ACCEPT", you confirm that you have read and are agreeing to our privacy policy and the use of ALL cookies. ACCEPT
Go to Top